Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial

Background Randomised controlled trials (RCTs) of psilocybin have reported large antidepressant effects in adults with major depressive disorder and treatment-resistant depression (TRD). Given psilocybin's psychedelic effects, all published studies have included psychological support. These eff...

Full description

Bibliographic Details
Main Authors: Muhammad Ishrat Husain, Daniel M. Blumberger, David J. Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D. Rosenblat, Benoit H. Mulsant
Format: Article
Language:English
Published: Cambridge University Press 2023-07-01
Series:BJPsych Open
Subjects:
Treatment-resistant depression
major depressive disorder
psilocybin
randomised controlled trial
psychedelic-assisted psychotherapy
Online Access:https://www.cambridge.org/core/product/identifier/S2056472423005355/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S2056472423005355/type/journal_article

Similar Items